"Since my first exposure to both benign and cancerous head and neck tumors, I have been driven to explore and provide the best possible patient care as it pertains to optimizing outcomes and quality of life. It is truly a privilege to take care of patients with complex head and neck issues and to be on the leading edge of head and neck surgical care and reconstruction. I treat each patient like they were my family member and strive to bolster their mental and physical well-being."


Dr. Barber's practice is dedicated to surgery for benign and cancerous head and neck tumours as well as facial plastic and reconstructive surgery. She strives to create active partnerships with her patients to achieve the best possible outcomes. 

Dr. Barber completed her M.D. and surgical residency training at the University of Alberta in Edmonton, Canada. She also completed a Master of Surgical Science at the University of Oxford for her dissertation work in peripheral nerve regeneration in head and neck cancer patients. She then went on to complete a fellowship in advanced head and neck cancer surgery and microvascular reconstruction at Mount Sinai Hospital in New York City. 



University of Alberta - Medical Education, 2011
University of Alberta - Otolaryngology-Head & Neck Surgery Residency, 2016
University of Oxford - Master of Surgical Science, 2017
University of Liverpool - Fellowship in Head and Neck Surgical Oncology, 2017
Icahn School of Medicine at Mount Sinai - Fellowship in Head and Neck Surgical Oncology & Microvascular Reconstruction

Board Certification: Otolaryngology-Head & Neck Surgery, 2017

Memberships: American Head and Neck Society, American Academy of Otolaryngology-Head & Neck Surgery

Awards and honors 

Dr. Barber has competed and been awarded in the National Poliquin Research competition and multiple other regional research grants previously. She has been awarded the R.E. Fraser Excellence in Teaching Award and clinical service awards for her excellence in patient care and teaching. She was awarded the prestigious Nilay Patel Memorial Award during her studies at the University of Oxford in 2016 for her work on distress management in head and neck cancer patients. Dr. Barber has given over 40 national and international podium presentations and has over 20 peer-reviewed publications pertaining to the treatment and care of head and neck cancer patients.

Academic interests 


Dr. Barber's clinical interests include head and neck cancer surgery, robotic surgery, and salivary and endocrine surgery. She has a special interest in reconstructive surgery for skin cancers. Her research interests include quality improvement in free flap reconstruction, peripheral nerve regeneration, cancer genomics, and HPV-related oropharyngeal cancer treatment.


Dr. Barber has a research interest in quality improvement of performance metrics in head and neck cancer surgery, quality of life and distress measurement in head and neck cancer, peripheral nerve regeneration, and de-escalation trials for HPV cancers. 

Recent Publications

Mair F, Erickson JR, Frutoso M, Konecny AJ, Greene E, Voillet V, Maurice NJ, Rongvaux A, Dixon D, Barber B, Gottardo R, Prlic M. Extricating human tumour immune alterations from tissue inflammation., Nature 2022 05; 605(7911):728-735

Chalker C, Voutsinas JM, Wu QV, Santana-Davila R, Hwang V, Baik CS, Lee S, Barber B, Futran ND, Houlton JJ, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Eaton KD, Rodriguez CP. Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients., Cancer Med 2022 Mar

Robinson EM, Lam AS, Solomon I, Brady JS, Pang J, Faraji F, Houlton JJ, Futran ND, Barber BR. Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma., Laryngoscope 2022 Feb

Chalker C, Santana-Davila R, Voutsinas JM, Wu QV, Hwang V, Baik CS, Lee S, Barber B, Futran ND, Houlton JJ, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Eaton KD, Rodriguez CP. High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors., J Palliat Med 2022 04; 25(4):614-619

Romine PE, Voutsinas J, Wu V, Tratt M, Liao J, Parvathaneni U, Barber B, Dillon J, Timoshchuk MA, Futran N, Houlton J, Laramore G, Martins R, Eaton KD, Rodriguez C. Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution., Oral Oncol 2021 12; 123105626